©The Author(s) 2025.
World J Diabetes. Dec 15, 2025; 16(12): 112799
Published online Dec 15, 2025. doi: 10.4239/wjd.v16.i12.112799
Published online Dec 15, 2025. doi: 10.4239/wjd.v16.i12.112799
Table 1 Characteristics and outcomes
| Clinical characteristics and FEC | Time 1, n = 106 |
| Baseline characteristics | |
| Age (year) | 46.2 ± 11.8 |
| Male sex | 53 (50) |
| Smoking | 29 (27.3) |
| Alcohol | 19 (17.9) |
| DM characteristics and control | |
| DM duration in years | 19.3 ± 9.7 |
| HbA1c (%) | 7.8 ± 1 |
| DM-related complications1 | 45 (42.5) |
| Retinopathy | 42 (39.6) |
| Kidney disease | 18 (17) |
| Neuropathy | 15 (14.2) |
| Cardiovascular disease | 1 (0.9) |
| Peripheral artery disease | 3 (2.8) |
| Fecal elastase concentration (µg/g), median (IQR) | 239.5 (266) |
| > 200 | 62 (58.5) |
| 100-200 | 21 (19.8) |
| < 100 | 23 (21.7) |
| Gastrointestinal symptoms | |
| No | 66 (62.3) |
| Yes2 | 40 (37.7) |
| Diarrhea | 6 (5.7) |
| Abdominal pain | 5 (4.7) |
| Dyspepsia | 33 (31.1) |
| Nutritional status | |
| BMI (kg/m2) | 25.2 ± 4.4 |
- Citation: Bolado F, Zabalza L, de-Carlos J, Tamayo-Rodríguez I, Prieto-Martínez C, Hervás-Palacios N. Longitudinal assessment of pancreatic exocrine dysfunction in type 1 diabetes. World J Diabetes 2025; 16(12): 112799
- URL: https://www.wjgnet.com/1948-9358/full/v16/i12/112799.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i12.112799